BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15

• Press Releases

  Dogwood Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025

  August 7, 2025

   · 

  3 min read
• Press Releases

  PacBio to Present at Upcoming Investor Conferences - August 6, 2025

  August 7, 2025

   · 

  1 min read
• Press Releases

  RenovoRx Expands U.S. Commercialization Efforts for the RenovoCath® Device with Growing Customer Demand and Key Leadership Hire

  August 7, 2025

   · 

  11 min read
• Press Releases

  Moleculin Biotech, Inc. Unveils Promising Preclinical Data of Annamycin in Liver Cancer Treatment

  August 7, 2025

   · 

  7 min read
• Press Releases

  Allogene Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update

  August 7, 2025

   · 

  2 min read
• Press Releases

  Actuate Therapeutics To Collaborate with Incyte Corporation and the University of Pittsburgh on Clinical Trial of Elraglusib in Combination with Retifanlimab and mFOLFIRINOX in Patients with Advanced Pancreatic Cancer

  August 7, 2025

   · 

  8 min read
• Press Releases

  Cingulate Submits New Drug Application to FDA for Lead ADHD Asset CTx-1301

  August 7, 2025

   · 

  6 min read
• Press Releases

  Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

  August 7, 2025

   · 

  19 min read
• Press Releases

  FDA approves expanded indication for AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in cytokine release syndrome (CRS)

  August 7, 2025

   · 

  8 min read
• Press Releases

  Imfinzi approved in Canada as first and only perioperative immunotherapy for muscle invasive bladder cancer

  August 7, 2025

   · 

  6 min read